Freund John Gordon
Director at COLL; Director at SIBN; Director at STRO, and 4 more
- Sold, on record
- $110M
- Dollars the filings state
- Form 4 sales
- 32
- Latest May 18, 2026
- Form 144 notices
- 1
- Proposed sales
- Companies
- 7
- Filed as an executive or holder
Companies
- COLLCOLLEGIUM PHARMACEUTICAL, INCDirector
- SIBNSI-BONE, Inc.Director
- STROSUTRO BIOPHARMA, INC.Director
- TETRAPHASE PHARMACEUTICALS INCDirector
- XENOPORT INCDirector
- Dicerna Pharmaceuticals IncOther
- TARAProtara Therapeutics, Inc.Director, 10% owner
Sales by reason
Form 4 sales per month, last 12 months.
Sales by company
- SIBN3.1M shares
- STRO1.4M shares
- TETRAPHASE PHARMACEUTICALS INC1M shares
- TARA56,038 shares
- Dicerna Pharmaceuticals Inc37,532 shares
- COLL22,407 shares
- XENOPORT INC909 shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 4 sale SIBNPlan not statedJun 16 2021
Sold 52,092 shares at $31.24 ($1.6M)
Freund John Gordon, Director
Sold 13.6% of holdings ($12M position)331,366 shares left0.3x usual sizeFiling
- 2 Form 144 notice SIBNNoticeAug 9 +784 days
Filed to sell 30,000 shares ($624k)
Freund John Gordon, Director
No 10b5-1 planFirst sale on recordFiling
- 3 Form 4 sale SIBNNo planAug 9 same day
Sold 30,000 shares at $20.54 ($616k)
Freund John Gordon, Director
No 10b5-1 planSold 22.4% of holdings ($2.8M position)103,899 shares leftFirst sale on recordFollows a Form 144Filing
- 4 Form 4 sale COLLNo planJun 9 +670 days
Sold 6,601 shares at $30.62 ($202k)
Freund John Gordon, Director
No 10b5-1 planSold 8.5% of holdings ($2.4M position)70,658 shares leftFirst sale on recordFiling
- 5 Form 4 sale SIBNNo planAug 8 +60 days
Sold 12,132 shares at $15.99 ($194k)
Freund John Gordon, Director
No 10b5-1 planSold 11.7% of holdings ($1.7M position)91,767 shares leftFiling
- 6 Form 4 sale COLLUnusualAug 8 same day
Sold 11,659 shares at $34.36 ($401k)
Freund John Gordon, Director
No 10b5-1 planSold 33.5% of holdings ($1.2M position)23,129 shares leftFiling
- 7 Form 4 sale COLLNo planMay 15 +280 days
Sold 4,127 shares at $34.54 ($143k)
Freund John Gordon, Director
No 10b5-1 planSold 4.7% of holdings ($3M position)83,972 shares leftFiling
- 8 Form 4 sale COLLNo planMay 18 +3 days
Sold 20 shares at $34.05 ($681)
Freund John Gordon, Director
No 10b5-1 planSold 0% of holdings ($2.9M position)83,952 shares left0x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (33)
| Source | ||||||||
|---|---|---|---|---|---|---|---|---|
| May 18, 2026 | COLL | Director | Form 4 sale | 20 | $681 | 0.0% | No plan | SEC |
| May 15, 2026 | COLL | Director | Form 4 sale | 4,127 | $143k | 4.7% | No plan | SEC |
| Aug 8, 2025 | COLL | Director | Form 4 sale | 11,659 | $401k | 33.5% | Unusual | SEC |
| Aug 8, 2025 | SIBN | Director | Form 4 sale | 12,132 | $194k | 11.7% | No plan | SEC |
| Jun 9, 2025 | COLL | Director | Form 4 sale | 6,601 | $202k | 8.5% | No plan | SEC |
| Aug 9, 2023 | SIBN | Director | Form 4 sale | 30,000 | $616k | 22.4% | No plan | SEC |
| Aug 9, 2023 | SIBN | Director | Form 144 notice | 30,000 | $624k | Notice | SEC | |
| Jun 16, 2021 | SIBN | Director | Form 4 sale | 52,092 | $1.6M | 13.6% | Plan not stated | SEC |
| May 28, 2021 | SIBN | Director | Form 4 sale | 71,587 | $2.2M | 15.7% | Plan not stated | SEC |
| May 26, 2021 | SIBN | Director | Form 4 sale | 69,861 | $2.3M | 13.3% | Plan not stated | SEC |
| Mar 17, 2021 | SIBN | Director | Form 4 sale | 721,253 | $21.9M | 57.9% | Unusual | SEC |
| Mar 15, 2021 | SIBN | Director | Form 4 sale | 235,887 | $7.3M | 15.9% | Plan not stated | SEC |
| Dec 3, 2020 | SIBN | Director | Form 4 sale | 147,886 | $3.4M | 9.1% | Plan not stated | SEC |
| Oct 19, 2020 | SIBN | Director, 10% owner | Form 4 sale | 190,053 | $4.2M | 8.2% | Plan not stated | SEC |
| Sep 18, 2020 | STRO | Director | Form 4 sale | 400,000 | $4.8M | 41.7% | Unusual | SEC |
| Sep 11, 2020 | STRO | Director | Form 4 sale | 500,000 | $5M | 34.2% | Unusual | SEC |
| Aug 19, 2020 | STRO | Director | Form 4 sale | 500,000 | $4.4M | 25.5% | Unusual | SEC |
| Jan 27, 2020 | SIBN | Director, 10% owner | Form 4 sale | 1M | $21.5M | 26.2% | Unusual | SEC |
| Dec 10, 2019 | TETRAPHASE PHARMACEUTICALS INC | Director | Form 4 sale | 15,031 | $33k | 100.0% | Unusual | SEC |
| Aug 26, 2019 | SIBN | Director, 10% owner | Form 4 sale | 152,424 | $2.8M | 3.8% | Plan not stated | SEC |
| Aug 23, 2019 | SIBN | Director, 10% owner | Form 4 sale | 47,576 | $959k | 1.2% | Plan not stated | SEC |
| Aug 12, 2019 | SIBN | Director, 10% owner | Form 4 sale | 400,000 | $7.3M | 9.0% | Plan not stated | SEC |
| Nov 11, 2015 | XENOPORT INC | Director | Form 4 sale | 909 | $6k | 0.2% | Plan not stated | SEC |
| Feb 20, 2015 | Dicerna Pharmaceuticals Inc | Other | Form 4 sale | 37,532 | $977k | 2.1% | Plan not stated | SEC |
| Oct 27, 2014 | TARA | Director, 10% owner | Form 4 sale | 56,038 | $560k | 3.8% | Plan not stated | SEC |
| Oct 2, 2014 | TETRAPHASE PHARMACEUTICALS INC | Director | Form 4 sale | 247,734 | $5.2M | 21.8% | Plan not stated | SEC |
| Sep 30, 2014 | TETRAPHASE PHARMACEUTICALS INC | Director | Form 4 sale | 152,266 | $3.1M | 11.8% | Plan not stated | SEC |
| Sep 17, 2014 | TETRAPHASE PHARMACEUTICALS INC | Director | Form 4 sale | 144,356 | $2.5M | 10.1% | Plan not stated | SEC |
| Sep 12, 2014 | TETRAPHASE PHARMACEUTICALS INC | Director | Form 4 sale | 55,644 | $946k | 3.7% | Plan not stated | SEC |
| Sep 8, 2014 | TETRAPHASE PHARMACEUTICALS INC | Director | Form 4 sale | 16,700 | $251k | 1.1% | Plan not stated | SEC |
| Sep 4, 2014 | TETRAPHASE PHARMACEUTICALS INC | Director | Form 4 sale | 183,300 | $2.8M | 10.8% | Plan not stated | SEC |
| Jun 23, 2014 | TETRAPHASE PHARMACEUTICALS INC | Director | Form 4 sale | 47,184 | $650k | 2.7% | Plan not stated | SEC |
| Jun 20, 2014 | TETRAPHASE PHARMACEUTICALS INC | Director | Form 4 sale | 152,816 | $2M | 8.1% | Plan not stated | SEC |